Guest guest Posted July 10, 2012 Report Share Posted July 10, 2012 Dear Parents, We would greatly appreciate your participation in the national FEND-Folate Study sponsored by town University Medical Center (IRB # 2009-162) and the Interactive Autism Network (Project # SR0039). " FEND " stands for fetal exposure to neuroactive drugs. Many families who are affected by autism spectrum and other pervasive developmental disorders are not included in medical studies and birth registries that track longer term childhood outcomes of prenatal exposure to neuroactive medications and folate. The FEND Study would like you to be our collaborator and help us disseminate this online risk assessment survey: http://www.surveymonkey.com/s.aspx?sm=qY4du_2bdtYao2HumBxcYjRA_3d_3d <http://www.surveymonkey.com/s.aspx?sm=qY4du_2bdtYao2HumBxcYjRA_3d_3d> .. This link takes you to a letter from the principal investigator that explains the impetus and specific aims of this initiative. If you read the letter and choose to participate in the survey, please know that participation is anonymous, encrypted, and takes 5 minutes to complete. Thank you for your cooperation! You are welcome to contact the principal investigator Dr. McVearry if you have any questions ( <tel:%28> or fendstudy@... ). You can find more information at our page, http://www.facebook.com/FendFolateStudy <http://www.facebook.com/FendFolateStudy> . Thank you for helping us accelerate understanding about prenatal exposure to neuroactive drugs and folate! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.